Trajenta (linagliptin): Reviews and patient testimonials

/static/themes-v3/default/images/default/opinion/traitement/intro.jpg?1564492295

Medication indications

Trajenta 5 mg film-coated tablets

Trajenta is indicated in adults with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control as:

monotherapy

• when metformin is inappropriate due to intolerance, or contraindicated due to renal impairment.

combination therapy

• in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4.4, 4.5 and 5.1 for available data on different combinations).


Route of administration: Oral
Molecule: linagliptin

Patients' opinions on Trajenta

In brief

General satisfaction level: Be the first to evaluate

Treatment's effectiveness: Be the first to evaluate

Ease of use: Be the first to evaluate

Adherence to prescription: Be the first to evaluate

Detected side effects: Be the first to evaluate

Improvement in the quality of life: Be the first to evaluate

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Not at all satisfied
10 = Extremely satisfied

1 = Never
10 = Always

1 = Not at all important
10 = Extremely important

1 = Not at all satisfied
10 = Extremely satisfied

Tips and advice of the community


avatar
Barges
on 03/03/2020

I was put on it after being taken off a weekly injection trulicity.got a terrible itching reaction and after 6 weeks still itching and was taken off after 3daysso not good.barbara

Your message

Members using this Trajenta

Conditions related to this medication

Fact sheet

Diabetes (Type 2)

See the fact sheet